27.3 C
New York
Thursday, June 11, 2026

Tag: TRI

Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson’s Disease

The Phase I trial of ENERGI-F705PD tablet was a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and pharmacokinetics of the investigational...

Zeekr Group Announces July 2025 Delivery Update

HANGZHOU, China, Aug. 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new...

Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone

SOUTHAMPTON, England, July 30, 2025 /PRNewswire/ -- MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the...

Trial Evaluating Blood Test for 10 Cancers Reaches Major Milestone

SOUTHAMPTON, England, July 30, 2025 /PRNewswire/ -- MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the...

H2O Audio and Florence Launch Limited-Edition TRI 2 Headphones in Celebration of Molokai2Oahu Paddleboard World Championships

SAN DIEGO and NEWPORT BEACH, Calif., July 30, 2025 /PRNewswire/ -- H2O Audio, the leader in waterproof, high-performance multisport headphones, has partnered with Florence...

Vexev and U.S. Renal Care Complete Enrollment in Groundbreaking Trial Evaluating Use of Robotic Ultrasound Scanning for AV Fistula Mapping in Dialysis Clinics

CANSCAN study enrolled 120 patients with chronic kidney disease using the investigational, semi-autonomous VxWave™ Ultrasound Imaging SystemThe VxWave Ultrasound Imaging System potentially provides important insights...

Boundless Devices announces the launch of the Motorola MQ20 Wi-Fi 6E Mesh Router with 6 GHz Coverage for Homes

IRVINE, Calif., July 28, 2025 /PRNewswire/ -- Boundless Devices Inc. (BDI), a global leader in telecommunications, smart networking and emerging mobile ecosystems is pleased...

U.S. GoldMining Applauds State of Alaska’s Plans to Advance Critical Road Infrastructure to the Whistler Gold-Copper Project, Alaska

ANCHORAGE, Alaska, July 28, 2025 /PRNewswire/ - U.S. GoldMining Inc. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") strongly commends the State of Alaska's recent announcement...

U.S. GoldMining Applauds State of Alaska’s Plans to Advance Critical Road Infrastructure to the Whistler Gold-Copper Project, Alaska

ANCHORAGE, Alaska, July 28, 2025 /CNW/ - U.S. GoldMining Inc. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") strongly commends the State of Alaska's recent announcement...

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

SHANGHAI and HONG KONG, July 28, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

SHANGHAI and HONG KONG, July 27, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...

Donanemab receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in early symptomatic Alzheimer’s disease

The opinion will now be referred to the European Commission for final regulatory decision on donanemab  INDIANAPOLIS, July 25, 2025 /PRNewswire/ -- Eli Lilly and...

Phase II Stage Of Pivotal Clinical Trial Of KX-826 Tincture 1.0% For The Treatment Of Male Adult Aga In China Reached Primary Endpoint

SUZHOU, China, July 25, 2025 /PRNewswire/ -- The Kintor Pharmaceutical Limited (the "Company") is pleased to announce that the Phase II Stage of the...

- A word from our sponsors -

spot_img
HomeTagsTRI